An Open-label Continuation Study Evaluating the Long-term Safety of Extended Release Ropinirole XL (Formerly CR) in Parkinson''s Disease
-
- STATUS
- Not Recruiting
-
- participants needed
- 419
-
- sponsor
- GlaxoSmithKline
Updated on 22 July 2024
Summary
To evaluate the safety profile of ropinirole XL during long-term treatment in subjects with early and advanced Parkinson's disease
Details
| Condition | Parkinson Disease, Parkinson's Disease |
|---|---|
| Age | 30years or above |
| Treatment | Ropinirole XL (formerly CR) |
| Clinical Study Identifier | NCT00632736 |
| Sponsor | GlaxoSmithKline |
| Last Modified on | 22 July 2024 |
How understandable was the trial content above?
Hard to understand
Easy to understand
Similar trials to consider
Loading...
Not finding what you're looking for?
Sign up as a volunteer to stay informed
Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.
Sign up as volunteerStudy Definition
WikipediaAdd a private note
- Select a piece of text.
- Add notes visible only to you.
- Send it to people through a passcode protected link.